Nigerian institution supports AfDB’s pharmaceutical Foundation
The National Institute for Pharmaceutical Research and Development (NIPRD) has pledged support for the emergent African Pharmaceutical Technology Foundation recently approved by the African Development Bank’s (AFDB) Board of Directors.
NIPRD’s Director-General, Dr Obi Adigwe, made this known in a statement issued on Wednesday in Lagos stating that the Foundation would enhance Africa’s access to technologies that underpin the manufacture of medicines, vaccines, and other pharmaceutical products significantly.
Adigwe added that the NIPRD had galvanised resources and stakeholders to enable it to play a crucial role in the continental initiative.
Read Also:
According to him, the Foundation fully aligns with NIPRD’s objective of conceptualisation of strong pan-African initiative where it has recorded many strides, particularly since the outbreak of COVID-19.
The director-general added that NIPRD had been involved as sponsor and as technical partner in a number of control trials to scientifically prove the efficacy of some conventional medicines currently at clinical trial phase.
He stated also that the institution emerged as a continental leader in the use of nanotechnology and Artificial Intelligence in drug discovery.
The institution played a seminal role in the articulation of the Medicines’ Security concept that links local manufacturing with access to healthcare and socioeconomic development, he added.
This, he explained, was especially in areas of job creation, technology transfer and revenue generation.
